Last 20 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.20 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.37 | 3.52 | 2.94 | 2.14 | 4.37 | 14.30 | 8.37 | 2.31 | 2.22 | 8.19 | 11.28 | 21.15 | 37.36 |
| — | -75.4% | -64.9% | -7.2% | +96.9% | +74.6% | -25.8% | -89.1% | -94.1% | -46.4% | — | — | — | |
| P/B Ratio | 0.17 | 0.92 | 0.60 | 0.52 | 1.33 | 1.33 | 1.41 | 0.91 | 0.98 | 0.95 | 0.86 | 2.69 | 2.49 |
| — | -30.9% | -57.1% | -42.7% | +35.0% | +39.5% | +64.4% | -66.4% | -60.5% | -42.9% | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Innovative Eyewear, Inc.'s operating margin was -287.5% in Q3 2025, up 87.3 pp QoQ and up 407.3 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of -348.9% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 56.6% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.1% | 36.6% | -2.2% | 48.5% | 13.6% | 23.4% | 17.9% | 1.8% | -29.3% | 36.2% | -17.5% | 7.1% | -293.4% |
| — | +56.6% | -112.2% | +2576.8% | +146.4% | -35.4% | +201.9% | -74.5% | +90.0% | +140.7% | -183.1% | -77.5% | -1335.1% | |
| Operating Margin | -484.2% | -287.5% | -374.8% | -418.9% | -314.6% | -694.8% | -639.6% | -525.4% | -412.6% | -719.7% | -785.2% | -986.0% | -2797.8% |
| — | +58.6% | +41.4% | +20.3% | +23.8% | +3.5% | +18.5% | +46.7% | +85.3% | +19.9% | -40.2% | -95.9% | -458.7% | |
| Net Margin | -474.6% | -274.8% | -363.6% | -391.4% | -307.8% | -678.5% | -631.2% | -514.1% | -388.7% | -699.1% | -757.8% | -987.3% | -2798.9% |
| — | +59.5% | +42.4% | +23.9% | +20.8% | +2.9% | +16.7% | +47.9% | +86.1% | +24.4% | -30.0% | -93.1% | -456.5% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -106.0% | -17.1% | -22.4% | -21.4% | -21.2% | -18.8% | -34.7% | -41.7% | -36.3% | -18.7% | -19.1% | -33.4% | -39.1% |
| — | +9.4% | +35.2% | +48.5% | +41.4% | -0.7% | -81.6% | -24.9% | +7.3% | +71.9% | — | — | +96.3% | |
| ROA | -96.7% | -15.9% | -21.2% | -20.0% | -19.8% | -17.7% | -30.8% | -35.7% | -33.4% | -17.8% | -17.8% | -29.2% | -33.8% |
| — | +10.2% | +31.1% | +44.0% | +40.6% | +0.5% | -72.6% | -22.4% | +1.1% | +52.4% | +83.7% | +77.1% | +81.1% | |
| ROIC | -153.6% | -40.0% | -55.3% | -32.8% | -25.4% | -33.4% | -106.7% | -119.7% | -76.1% | -32.7% | -42.6% | -134.4% | -224.1% |
| — | -19.7% | +48.1% | +72.6% | +66.7% | -2.3% | -150.3% | +10.9% | +66.1% | +79.0% | +70.4% | +20.3% | +10.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 28.8% YoY to 11.98x, tightening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | 0.01 | — | — | — | — | — | 0.02 |
| — | — | — | — | — | — | — | — | — | — | — | — | -98.9% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 12.52 | 11.98 | 18.70 | 16.39 | 12.52 | 16.83 | 14.73 | 4.65 | 8.99 | 17.40 | 26.53 | 9.00 | 7.07 |
| — | -28.8% | +26.9% | +252.2% | +39.2% | -3.2% | -44.5% | -48.3% | +27.3% | +142.6% | +9736.9% | +2233.8% | +576.6% | |
| Quick Ratio | 11.40 | 10.13 | 15.93 | 13.87 | 11.40 | 15.43 | 12.71 | 3.61 | 7.62 | 15.60 | 24.53 | 7.53 | 6.91 |
| — | -34.3% | +25.4% | +283.7% | +49.5% | -1.0% | -48.2% | -52.0% | +10.3% | +142.1% | +21642.3% | +4805.6% | +1055.6% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | -1216.31 | -736.95 | -465.15 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 20 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying LUCY stock.
Innovative Eyewear, Inc.'s current P/E is -0.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Innovative Eyewear, Inc.'s current operating margin is -484.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Innovative Eyewear, Inc.'s business trajectory between earnings reports.